The 24-Hour Economy and Accelerated Export Development Programme Secretariat has extended the deadline for prospective tenants of the Legon Pharmaceutical Innovation Park (LePIP) to October 31, 2026, as Ghana seeks to expand local medicine production, attract industrial investment and reduce dependence on imported pharmaceuticals.
The extension gives eligible pharmaceutical manufacturers and other businesses additional time to submit Expressions of Interest (EOIs) to establish operations within the planned pharmaceutical and life sciences industrial park in the Greater Accra Region.
The Secretariat said in a statement issued in Accra that LePIP was a flagship industrial transformation project under the 24-Hour Economy Programme, designed to strengthen domestic manufacturing capacity, support pharmaceutical research and development, expand exports and create employment.
The project is planned as a 2,000-acre industrial ecosystem, beginning with a 40-hectare pilot pharmaceutical manufacturing platform within the Osudoku/Ningo Prampram enclave.
For Ghana, the initiative presents an opportunity to build domestic capacity in a sector where greater local production could help reduce exposure to imported medicine supply disruptions and create opportunities for businesses involved in manufacturing, packaging, distribution and related services.
The Secretariat said the park would provide an integrated industrial environment for pharmaceutical production, research and development, quality assurance, logistics and other supporting activities.
Planned infrastructure includes reliable electricity and water supply, shared utilities, centralised quality-control and testing laboratories, warehousing, cold-chain facilities, environmental management systems, regulatory support and digital infrastructure.
Such shared facilities could help participating manufacturers access essential industrial services without having to develop every component independently, potentially easing some barriers to establishing pharmaceutical production facilities.
The first phase is projected to create more than 3,000 direct jobs, with an estimated 30,000 additional jobs expected in subsequent phases, according to the statement.
Several thousand indirect employment opportunities are also anticipated across manufacturing, packaging, logistics, engineering, research and related services.
The project is further expected to support technical skills development through a Pharmaceutical Manufacturing Centre of Excellence to be established in partnership with the University of Ghana.
The centre is projected to supply more than 1,000 skilled workers to the pharmaceutical industry within its first five years, helping address the specialised workforce requirements of local pharmaceutical manufacturing.
However, the park’s contribution to import substitution and export growth will depend on its ability to attract manufacturers, mobilise investment, establish the required infrastructure and meet pharmaceutical quality and regulatory standards.
The Secretariat has encouraged eligible pharmaceutical manufacturers and other prospective tenants to submit their Expressions of Interest before the revised deadline of October 31, 2026.
